These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26403951)

  • 1. Mass-Selected Site-Specific Core-Fucosylation of Serum Proteins in Hepatocellular Carcinoma.
    Yin H; Tan Z; Wu J; Zhu J; Shedden KA; Marrero J; Lubman DM
    J Proteome Res; 2015 Nov; 14(11):4876-84. PubMed ID: 26403951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass Spectrometric N-Glycan Analysis of Haptoglobin from Patient Serum Samples Using a 96-Well Plate Format.
    Zhu J; Wu J; Yin H; Marrero J; Lubman DM
    J Proteome Res; 2015 Nov; 14(11):4932-9. PubMed ID: 26448449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass-selected site-specific core-fucosylation of ceruloplasmin in alcohol-related hepatocellular carcinoma.
    Yin H; Lin Z; Nie S; Wu J; Tan Z; Zhu J; Dai J; Feng Z; Marrero J; Lubman DM
    J Proteome Res; 2014 Jun; 13(6):2887-96. PubMed ID: 24799124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies.
    Zhu J; Lin Z; Wu J; Yin H; Dai J; Feng Z; Marrero J; Lubman DM
    J Proteome Res; 2014 Jun; 13(6):2986-97. PubMed ID: 24807840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly enhanced fucosylation of serum glycoproteins in patients with hepatocellular carcinoma.
    Naitoh A; Aoyagi Y; Asakura H
    J Gastroenterol Hepatol; 1999 May; 14(5):436-45. PubMed ID: 10355508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of tumour suppressor genes
    El-Bendary M; Nour D; Arafa M; Neamatallah M
    Br J Biomed Sci; 2020 Jan; 77(1):35-40. PubMed ID: 31790342
    [No Abstract]   [Full Text] [Related]  

  • 8. A simple diagnostic index comprising epithelial membrane antigen and fibronectin for hepatocellular carcinoma.
    Attallah AM; El-Far M; Abdel Malak CA; Farid K; Omran MM; Yahya RS; Saad EA; Albannan MS; Attallah AA; El Basuni MA; Ali IS; Abed SB; El Naggar MA
    Ann Hepatol; 2015; 14(6):869-80. PubMed ID: 26436359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase.
    Yang JD; Dai J; Singal AG; Gopal P; Addissie BD; Nguyen MH; Befeler AS; Reddy KR; Schwartz M; Harnois DM; Yamada H; Gores GJ; Feng Z; Marrero JA; Roberts LR
    Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1085-1092. PubMed ID: 28258053
    [No Abstract]   [Full Text] [Related]  

  • 10. Biomarker discovery for early detection of hepatocellular carcinoma in hepatitis C-infected patients.
    Mustafa MG; Petersen JR; Ju H; Cicalese L; Snyder N; Haidacher SJ; Denner L; Elferink C
    Mol Cell Proteomics; 2013 Dec; 12(12):3640-52. PubMed ID: 24008390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients.
    Zekri AR; Youssef AS; Bakr YM; Gabr RM; El-Rouby MN; Hammad I; Ahmed EA; Marzouk HA; Nabil MM; Hamed HA; Aly YH; Zachariah KS; Esmat G
    Asian Pac J Cancer Prev; 2015; 16(3):1281-7. PubMed ID: 25735368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum MicroRNAs as Biomarkers in Hepatitis C: Preliminary Evidence of a MicroRNA Panel for the Diagnosis of Hepatocellular Carcinoma.
    Weis A; Marquart L; Calvopina DA; Genz B; Ramm GA; Skoien R
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
    Ismail MM; Morsi HK; Abdulateef NA; Noaman MK; Abou El-Ella GA
    Scand J Clin Lab Invest; 2017 May; 77(3):175-183. PubMed ID: 28276727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Online Calculator Based on Serum Biomarkers to Detect Hepatocellular Carcinoma among Patients with Hepatitis B.
    Yang T; Xing H; Wang G; Wang N; Liu M; Yan C; Li H; Wei L; Li S; Fan Z; Shi M; Chen W; Cai S; Pawlik TM; Soh A; Beshiri A; Lau WY; Wu M; Zheng Y; Shen F
    Clin Chem; 2019 Dec; 65(12):1543-1553. PubMed ID: 31672853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection.
    Nakano M; Kawaguchi T; Nakamoto S; Kawaguchi A; Kanda T; Imazeki F; Kuromatsu R; Sumie S; Satani M; Yamada S; Torimura T; Kakuma T; Yokosuka O; Sata M
    Oncol Rep; 2013 Nov; 30(5):2049-55. PubMed ID: 23982634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum heat shock protein 27 levels in patients with hepatocellular carcinoma.
    Gruden G; Carucci P; Lolli V; Cosso L; Dellavalle E; Rolle E; Cantamessa A; Pinach S; Abate ML; Campra D; Brunello F; Bruno G; Rizzetto M; Perin PC
    Cell Stress Chaperones; 2013 Mar; 18(2):235-41. PubMed ID: 23073653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of MAGE-4 protein in the sera of patients with hepatitis-C virus-associated hepatocellular carcinoma and liver cirrhosis.
    Tsuzurahara S; Sata M; Iwamoto O; Shichijo S; Kojiro M; Tanikawa K; Itoh K
    Jpn J Cancer Res; 1997 Sep; 88(9):915-8. PubMed ID: 9369941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum protein biomarkers screening in HCC patients with liver cirrhosis by ICAT-LC-MS/MS.
    Kang X; Sun L; Guo K; Shu H; Yao J; Qin X; Liu Y
    J Cancer Res Clin Oncol; 2010 Aug; 136(8):1151-9. PubMed ID: 20130913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.
    Caviglia GP; Abate ML; Gaia S; Petrini E; Bosco C; Olivero A; Rosso C; Ciancio A; Pellicano R; Saracco GM; Rizzetto M; Smedile A
    Panminerva Med; 2017 Dec; 59(4):283-289. PubMed ID: 28650134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.